Navigation Links
Kentucky Pharmacists Event Urging Senate Minority Leader McConnell to Fix Flawed Medicaid Drug Reimbursement Rule
Date:12/3/2007

FRANKFORT, Ky., Dec. 3 /PRNewswire-USNewswire/ -- Kentucky pharmacist press conference to discuss new Medicaid generic prescription drug reimbursement rule and the need for Sen. Mitch McConnell (R-Ky.) to use his power to make sure the legislative fix is considered before Congress adjourns for the year. The rule, scheduled to be fully implemented in early 2008, will grossly underpay pharmacists and puts patient access at risk.

WHO:

Brad Hall, Executive Director of the Kentucky Pharmacists Association

Mac Bray, RPh, Owner of Capital Pharmacy and Medical Equipment in Frankfort

Larry Hadley, RPh, Co-Owner of Wayne's Pharmacy in Frankfort

WHEN:

December 6, 2007, at 10:00 a.m.

WHERE:

Capital Pharmacy and Medical Equipment

662 East Main Street

Frankfort, KY

502-223-2827

WHY:

The Centers for Medicare and Medicaid Services published the Medicaid reimbursement rule on July 17, and the implementation process will be completed in early 2008. At that time, community pharmacies will be faced with a burden that could not only cause difficulty in participating in the Medicaid program, but sustainability in the business community. These challenges will be due to low reimbursement rates based on an inaccurate Average Manufacturer Price (AMP) formula. According to a Government Accountability Office report, on average, pharmacies will be paid 36 percent below their acquisition costs for the generic prescriptions of Medicaid patients.

Sen. McConnell can help move the legislative fix S.1951, the Fair Medicaid Drug Payment Act of 2007, through the Senate before it is too late. The bill contains measures that achieve fairness with the reimbursement system and preserving patient access to prescription drugs by:

-- Removing discounted mail order and pharmacy benefit manager

prices that are unavailable to community pharmacies and unfairly

lower than the overall AMP formula

-- Requiring Medicaid payment be calculated using the weighted average

of the Medicaid generic drugs based on their actual utilization

-- Restoring the practice of using three available generic products

for the calculation; increases the maximum allowable reimbursement

from 250 percent of the AMP to 300 percent

-- Encouraging more inexpensive generic drug usage by requiring prior

authorization of brand name drugs.

CONTACT:

For more information contact Chip Riddleberger at 410-725-6024 or chip.riddleberger@ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Anthem Blue Cross and Blue Shield in Kentucky Announces the Availability of New Health Plans for Medicare Beneficiaries
2. Nurses From Across Nation Join Solidarity Caravan in Support of Striking Kentucky RNs
3. Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index
4. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
5. CVS Caremark Celebrates American Pharmacists Month by Thanking Its 20,000 Pharmacists
6. Maryland Pharmacists Urge House Majority Leader Hoyer to Put Patients First
7. Lisa Camooso Miller Joins National Community Pharmacists as Vice President of Public Affairs
8. By 2012, Prescribing Pharmacists Could Influence $145 Billion in Drug Sales
9. CVS Pharmacists Serve a Vital Role in Helping Patients Manage Diabetes
10. Pharmacists Press Conference Urging Senate Majority Leader Harry Reid to Fix Flawed Medicaid Drug Reimbursement Rule
11. The American Pharmacists Association Supports Consumer Education About OTC Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... ... ... Usually, the impending arrival of warmer weather means the gleeful banishment of ... chin, this means more anxiety than elation. The cosmetic dermatology experts at Cosmetic Laser ... chin is undesirable,” Dr. Goldman said, “but it seems doubly so when the fat ...
(Date:3/28/2017)... ... March 28, 2017 , ... ... release of two biometric time and attendance tracking products: the new NCheck Cloud ... NCheck Cloud Bio Attendance uses biometric face recognition to enable users to check ...
(Date:3/28/2017)... ... ... Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio and New ... sit on the 2017 National Advisory Board for Allergan’s Facial Aesthetics National Advisory Board., ... the clinic from a small start-up to number 78 in the country based on ...
(Date:3/28/2017)... ... March 28, 2017 , ... The Lice ... Atlantic City March 13-16, was a busy spot this year. Liz Solovay and ... strategies for preventing outbreaks among camp communities during the upcoming 2017 camping season. ...
(Date:3/28/2017)... ... March 28, 2017 , ... Nurse practitioners ... as their value increases in the healthcare workforce, according to a survey recently ... boards, career fairs, and candidate leads to healthcare employers of physicians and advanced ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... Israel , March 28, 2017 Emosis ... This new business entity, Emosis Ltd, headquartered in Tel ... of novel assays complementing the mother company existing technology platform and ... and sales development of Emosis kits. ... This strategic move starts building Emosis international footprint. ...
(Date:3/28/2017)... 2017  AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a ... commercialization of innovative therapies for the treatment of ... Agency (EMA) has notified the company that the ... Application (MAA) has passed validation, and that the ... MAA for ARX-04 (known as DSUVIA™ in the ...
(Date:3/28/2017)... Mass. , March 28, 2017 ... company developing innovative therapeutics that address significant unmet ... a patent from the Japan Patent Office (JPO) ... connective tissue growth factor (CTGF) for the treatment ... limited to skin fibrosis and proliferative retinopathy (Japanese ...
Breaking Medicine Technology: